Wei Gu
Impact in
- Pharmacology top 10%
- Healthcare and Venom Research
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Co-authors
- Norman B. Hecht (3 shared papers)Changquan Ling (11 shared papers)Fanfu Fang (7 shared papers)Min Li (4 shared papers)Yuwei Qiu (1 shared paper)Feng Huang (2 shared papers)Jingxiang Wu (1 shared paper)Yunyun Zhang (1 shared paper)
- Journals
- Journal of Integrative Medicine (5 papers)Pain Research and Management (2 papers)Integrative Cancer Therapies (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Gu
68 papers receiving 888 citations
Peers
Comparison fields: 5 of 107
- Complementary and alternative medicine 63
- Pharmacology 104
- Reproductive Medicine 51
- Anesthesiology and Pain Medicine 27
- Orthopedics and Sports Medicine 37
Countries citing papers authored by Wei Gu
This map shows the geographic impact of Wei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Gu more than expected).
Fields of papers citing papers by Wei Gu
This network shows the impact of papers produced by Wei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Gu. The network helps show where Wei Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 52 | |
| 2 | 2022 | 49 | |
| 3 | 2004 | 47 | |
| 4 | 2015 | 46 | |
| 5 | 1995 | 42 | |
| 6 | 2013 | 40 | |
| 7 | 2017 | 39 | |
| 8 | 2009 | 36 | |
| 9 | 2012 | 32 | |
| 10 | 2019 | 30 | |
| 11 | Triple-controlled oncolytic adenovirus expressing melittin to exert inhibitory efficacy on hepatocellular carcinoma. | 2015 | 28 |
| 12 | 2017 | 24 | |
| 13 | 1996 | 24 | |
| 14 | 2023 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 21 | |
| 17 | 2017 | 20 | |
| 18 | 2014 | 19 | |
| 19 | Transcription elongation by RNA polymerase II: mechanism of SII activation. | 1993 | 18 |
| 20 | 2019 | 18 |
About Wei Gu
Wei Gu is a scholar working on Molecular Biology, Oncology, Complementary and alternative medicine, Surgery and Pharmacology, having authored 74 papers that have together received 901 indexed citations. Recurring topics across this work include Antioxidants, Aging, Portulaca oleracea (4 papers), HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Complementary and Alternative Medicine Studies (3 papers), Acupuncture Treatment Research Studies (2 papers), Healthcare and Venom Research (2 papers), Musculoskeletal pain and rehabilitation (2 papers) and Biochemical Acid Research Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Pharmacology (104 citations), Reproductive Medicine (51 citations), Anesthesiology and Pain Medicine (27 citations) and Orthopedics and Sports Medicine (37 citations). Wei Gu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Norman B. Hecht, Changquan Ling, Fanfu Fang, Min Li, Yuwei Qiu, Feng Huang, Jingxiang Wu, Yunyun Zhang, Mingye Zhao and Li Bai. Their work appears in journals such as Journal of Integrative Medicine, Pain Research and Management, Integrative Cancer Therapies, Evidence-based Complementary and Alternative Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.